Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Roux

Showing results (511-520 of 522) with videos related to

Pageof 53
Sort By:
Schizophrenia Research|September 11, 2017
Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ datasetG Fond, L Boyer, M Andrianarisoa, et al.
Nature Communications|May 31, 2023
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancerDzana Dervovic, Ahmad A Malik, Edward L Y Chen, et al.
Cell Reports|June 19, 2026
Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanismThomas Boyer, Céline Blaye, Domitille Chalopin, et al.
Nature Communications|September 5, 2023
Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancerDzana Dervovic, Ahmad A Malik, Edward L Y Chen, et al.
Bulletin Du Cancer|November 20, 2001
[Standards, options and recommendations: Good clinical practice in the dietetic management of cancer patients: hospital catering]F Dayot, A Bataillard, C Keré, et al.
Cell Reports|June 5, 2024
Immunotherapeutic targeting of surfaceome heterogeneity in AMLMarie-Eve Bordeleau, Éric Audemard, Arnaud Métois, et al.
Biomarker Research|April 14, 2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemiaArnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.
Cancer Cell|July 10, 2019
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid LeukemiaIrène Baccelli, Yves Gareau, Bernhard Lehnertz, et al.
Blood Advances|September 20, 2023
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic ArchitectureJasmin Coulombe-Huntington, Thierry Bertomeu, Caroline Huard, et al.
Pageof 53

Showing results (511-520 of 522) with videos related to

Sort By:
Pageof 53
Schizophrenia Research|September 11, 2017
Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ datasetG Fond, L Boyer, M Andrianarisoa, et al.
Nature Communications|May 31, 2023
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancerDzana Dervovic, Ahmad A Malik, Edward L Y Chen, et al.
Cell Reports|June 19, 2026
Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanismThomas Boyer, Céline Blaye, Domitille Chalopin, et al.
Nature Communications|September 5, 2023
Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancerDzana Dervovic, Ahmad A Malik, Edward L Y Chen, et al.
Bulletin Du Cancer|November 20, 2001
[Standards, options and recommendations: Good clinical practice in the dietetic management of cancer patients: hospital catering]F Dayot, A Bataillard, C Keré, et al.
Cell Reports|June 5, 2024
Immunotherapeutic targeting of surfaceome heterogeneity in AMLMarie-Eve Bordeleau, Éric Audemard, Arnaud Métois, et al.
Biomarker Research|April 14, 2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemiaArnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.
Cancer Cell|July 10, 2019
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid LeukemiaIrène Baccelli, Yves Gareau, Bernhard Lehnertz, et al.
Blood Advances|September 20, 2023
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic ArchitectureJasmin Coulombe-Huntington, Thierry Bertomeu, Caroline Huard, et al.
Pageof 53